Reporter
VUMC initiative to address social drivers of health
Oct. 19, 2023—Vanderbilt University Medical Center has received a federal grant to incorporate social drivers of health into adult primary care with the aim of improving outcomes for patients with multiple chronic conditions.
VUMC co-hosts the 2023 Mid-South Addiction Conference Oct. 27 and 28
Oct. 19, 2023—The second-annual 2023 Mid-South Addiction Conference is Oct. 27 and 28 at Vanderbilt University Medical Center.
Department of Radiology to host third annual Diversity, Equity and Inclusion Week
Oct. 18, 2023—The Department of Radiology and Radiological Sciences at Vanderbilt is set to host its third annual Diversity, Equity, and Inclusion Week Oct. 23-27
VUMC’s Wei Kelly Wu, Siru Liu named 2023 Stat Wunderkinds
Oct. 18, 2023—Vanderbilt's Wei Kelly Wu, MD, and Siru Liu, PhD, have been named 2023 Stat Wunderkinds.
Powers announces plan to step down from key diabetes leadership roles
Oct. 17, 2023—Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.
VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies
Oct. 17, 2023—A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.
Vanderbilt’s Ellen Clayton and Allison McCoy elected fellows of ACMI
Oct. 17, 2023—Vanderbilt’s Ellen Clayton, MD, JD, and Allison McCoy, PhD, have been elected to the American College of Medical Informatics (ACMI) class of 2023.
AI predicts blood clot risk in hospitalized children: VUMC study
Oct. 17, 2023—An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.
Vanderbilt-Ingram Cancer Center earns NCI Merit Award
Oct. 17, 2023—Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
Oct. 17, 2023—A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.
How biostatistics saves lives: the Vanderbilt experience
Oct. 17, 2023—Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.
VUMC scientists record powerful signal in the brain’s white matter
Oct. 16, 2023—Vanderbilt researchers report that when people who are having their brains scanned by fMRI perform a task, like wiggling their fingers, certain signals increase in white matter throughout the brain, which has long been thought to play a lesser role the more the brain's more energetic gray matter.
